期刊文献+

口腔扁平苔藓的诊断及鉴别诊断 被引量:4

原文传递
导出
摘要 口腔扁平苔藓(OLP)是口腔黏膜常见病,目前对OLP的诊断多根据病史、口腔黏膜病损、皮肤、指(趾)甲病损,但对临床症状不典型病例的诊断及鉴别诊断是亟待解决的问题。本文就近几年国内外学者关于OLP的研究进行总结,归纳出有一定临床意义及应用前景的辅助诊断方法。
出处 《临床口腔医学杂志》 2006年第11期694-697,共4页 Journal of Clinical Stomatology
  • 相关文献

参考文献22

  • 1周刚,徐学义.口腔扁平苔藓的分类[J].临床口腔医学杂志,2003,19(4):242-243. 被引量:10
  • 2Van der Meij EH, Schepman KP, Smeele LE, et al. A review of the recent literature regarding malignant transformation of oral lichen planus[J]. Oral Stag Oral Med Oral Pathol, 1999, 88: 307-310.
  • 3PB Sugerman, NW Savage. Oral Lichen Planus [J]. Clinics in Dermatology, 2000, 18: 533-539.
  • 4Walsh I.,J,Savage W,Ishii T, et al. Immunopathogenesis of oral lichen planus[J].J Oral Pathol Med, 1990, 19: 389-396.
  • 5Dekker NP, Lozada Nur F, Lag enaur LlA,et al.Apoptosis-associat edmarkersin oral lichen planus [J]. J Oral Pathol Med, 1997, 26(4) : 170-175.
  • 6杨慧,刘宁,傅颖媛,曾小平,曹军,宗娟娟.口腔扁平苔藓患者免疫功能的实验研究[J].临床口腔医学杂志,2001,17(3):217-218. 被引量:12
  • 7Freed berg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's dermatology in general medicine [M]. 5th ed. New York: McGraw Hill, 1999.756-760.
  • 8Sklavounou AD. Serum immunoglobulins and complement (C3)in oraI Iichenplanus[J]. Oral Surg, 1985, 55: 47.
  • 9Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2, -4, -10, tumor necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus [J]. Arch Oral Biol, 1999, 44(6): 499-507.
  • 10Grabbe S, KoldelG. Coexisting Lichen planus and subacute cutaneous Lupus erythematosus [J].Clin Exp Dermatol, 1995, 20 (3):249-254.

二级参考文献25

  • 1林梅,周敏.复方苔藓片对口腔扁平苔藓患者血小板电泳时间的影响[J].口腔医学纵横,1995,11(4):214-215. 被引量:1
  • 2陈谦明,罗刚,周敏.口腔扁平苔藓患者组织中超氧化物歧化酶和过氧化脂质的测定及意义[J].华西口腔医学杂志,1996,14(4):269-271. 被引量:5
  • 3傅颖媛.香菇菌发酵液对小鼠免疫功能的调节作用[J].中国免疫学杂志,1993,9:202-202.
  • 4Bikfalvi A,Klein S,Pintucci G,et a1.Biological roles of fibroblast growth factor-2.Endocr Rev,1997,18(1):26.
  • 5Yamamoto T,Osaki T,Yoneda K,et a1.Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus.J Oral Pathol Med,1994,23(7):309.
  • 6Yin XM, Oltvai ZN, Konsmeyer SJ, et al. BH1and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax[J]. Nature, 1994,369(26):321-323.
  • 7Stanislaw K, Maryla K, Ahmed S, et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2 [J]. Am J Pathol, 1994,145(6):1323-1336.
  • 8Jennifer K, Grace B,Richard CK,et al. Pattern of p53 and Ki67protein expression in epithelial dysplasia from the floor of the mouth[J]. J Pathol,1997,183(2):418-423.
  • 9Singh BB, Chandler FW Jr, Whitaker SB,et al. Immunohistochemical evaluation of Bcl-2 oncoprotein in oral dysplasia and carcinoma[J]. Oral Surg Oral Med Oral Pathol, 1998,85(6):692-697.
  • 10Loro LL, Vintermyr OK, Liavaag PG,et al. Oral squamous cell carcinoma is associated with decreased Bcl-2/bax expression ratio and increased apoptosis[J]. Hum Pathol, 1999,30(9):1097-1105.

共引文献42

同被引文献16

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部